Filing Details
- Accession Number:
- 0000874015-18-000033
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2018-01-31 16:15:25
- Reporting Period:
- 2018-01-29
- Accepted Time:
- 2018-01-31 16:15:25
- Original Submission Date:
- 2018-01-29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Ionis Pharmaceuticals Inc | IONS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 897667 | T Stanley Crooke | C/O Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-29 | 10,000 | $14.69 | 61,733 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-29 | 10,000 | $54.12 | 51,733 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-01-29 | 1,000 | $10.82 | 5,128 | No | 4 | M | Indirect | By wife |
| Common Stock | Disposition | 2018-01-29 | 1,000 | $54.12 | 4,128 | No | 4 | S | Indirect | By wife |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Indirect | By wife |
| No | 4 | S | Indirect | By wife |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-01-29 | 10,000 | $0.00 | 10,000 | $14.69 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-01-29 | 1,000 | $0.00 | 1,000 | $10.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 26,642 | 2017-01-02 | 2020-01-29 | No | 4 | M | Direct |
| 6,904 | 2017-01-02 | 2020-01-01 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 725,391 | Indirect | By trust |
Footnotes
- Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 6/20/2016.
- Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person's wife on 6/17/2016.
Billionaire Hedge Funds
